SnowSpark delivers proprietary AI-powered compliance intelligence for pharma submissions, surfacing risk patterns ahead of regulatory review. A provisional patent filing establishes a first-mover position in AI-assisted regulatory compliance.
Private walkthroughs available by request. Actively onboarding design partners and qualified investors.
Priority for compliance leads and regulatory affairs executives
Haliya is building a second product in a related vertical, expanding the platform into a broader compliance infrastructure play. Full details are available to qualified investors under a mutual NDA.
Product details available to qualified investors and strategic partners under a mutual NDA.
For qualified investors and strategic partners only
Haliya is raising its pre-seed round with a clear path to Series A and Series B. We welcome investors, pharma compliance executives, and federal agency leaders.
Responses within 2 business days · michaela@haliya.ai